Jingjing Ye

3.9k total citations
128 papers, 2.9k citations indexed

About

Jingjing Ye is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Jingjing Ye has authored 128 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 18 papers in Pathology and Forensic Medicine and 18 papers in Oncology. Recurrent topics in Jingjing Ye's work include Acute Myeloid Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (12 papers) and RNA modifications and cancer (8 papers). Jingjing Ye is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (12 papers) and RNA modifications and cancer (8 papers). Jingjing Ye collaborates with scholars based in China, United States and Belgium. Jingjing Ye's co-authors include Chunyan Ji, Pengbo Wan, Daoxin Ma, Hui Liao, Liqun Zhang, Liqun Zhang, Min Gong, Jian Xiao, Ming Zheng and Chunling Xu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Jingjing Ye

120 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingjing Ye China 30 1.2k 662 356 351 338 128 2.9k
Chul‐Ho Kim South Korea 34 1.1k 0.9× 515 0.8× 289 0.8× 371 1.1× 202 0.6× 141 3.2k
Xinyu Wu China 31 1.4k 1.1× 374 0.6× 222 0.6× 295 0.8× 499 1.5× 167 3.6k
Jie Shen China 27 1.5k 1.2× 446 0.7× 301 0.8× 332 0.9× 651 1.9× 88 4.0k
Yong Xu China 27 784 0.6× 702 1.1× 552 1.6× 179 0.5× 190 0.6× 97 3.2k
Lingling Xu China 32 808 0.7× 1.3k 1.9× 268 0.8× 257 0.7× 328 1.0× 105 2.7k
Liangxue Zhou China 33 1.0k 0.8× 786 1.2× 833 2.3× 716 2.0× 225 0.7× 117 3.5k
In‐Sun Hong South Korea 27 1.3k 1.1× 864 1.3× 610 1.7× 659 1.9× 499 1.5× 91 3.7k
Jialin Song China 27 902 0.7× 698 1.1× 433 1.2× 281 0.8× 587 1.7× 83 2.7k

Countries citing papers authored by Jingjing Ye

Since Specialization
Citations

This map shows the geographic impact of Jingjing Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Ye more than expected).

Fields of papers citing papers by Jingjing Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Ye. The network helps show where Jingjing Ye may publish in the future.

Co-authorship network of co-authors of Jingjing Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Ye. A scholar is included among the top collaborators of Jingjing Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Ye. Jingjing Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Ting, Xinsheng Li, Quan Zou, et al.. (2024). A Non‐Metallic Nanozyme Ameliorates Pulmonary Hypertension Through Inhibiting ROS/TGF‐β1 Signaling. Advanced Healthcare Materials. 13(30). e2401909–e2401909. 4 indexed citations
3.
Zhang, Yan, Jingjing Ye, Hao Chen, Daobin Zhou, & Chunyan Ji. (2024). Efficacy and Safety of BTKis in Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis. Cancers. 16(5). 860–860. 3 indexed citations
4.
Ye, Jingjing, Lin Weng, Bo Jia, et al.. (2023). CMTM3 deficiency induces cardiac hypertrophy by regulating MAPK/ERK signaling. Biochemical and Biophysical Research Communications. 667. 162–169. 3 indexed citations
5.
Liu, Liming, Zhao Yuan, Shan Liu, Jingjing Ye, & Lixue Chen. (2023). Study on cathode spot expansion process in vacuum arc with high di/dt. Vacuum. 211. 111984–111984. 6 indexed citations
6.
Ye, Jingjing, et al.. (2023). Bifunctional three-way DNA junction-based strand displacement recycling for amplifiable electrochemical bivariate biosensing. Sensors and Actuators B Chemical. 390. 133986–133986. 2 indexed citations
7.
Gao, Jiaxi, Chunli Yang, Wu Xu, et al.. (2023). A highly sensitive electrochemical biosensor via short-stranded DNA activating LAMP(H+) to regulate i-motif folds for signal transduction. Sensors and Actuators B Chemical. 380. 133354–133354. 17 indexed citations
8.
Ye, Jingjing, et al.. (2023). Effect of 3D Animation Combined with Teach-Back Health Education on Pelvic Floor Muscle Training in LARS Patients: A Randomized Controlled Trial. Journal of Nursing Management. 2023. 1–9. 3 indexed citations
9.
Sun, Tao, Guosheng Li, Yuan Xia, et al.. (2023). DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy. Advanced Science. 10(19). e2205854–e2205854. 2 indexed citations
10.
Wang, Dongmei, Tao Sun, Zhe Zhao, et al.. (2023). Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation. Nature Communications. 14(1). 6907–6907. 6 indexed citations
11.
Shen, Ziyuan, Cai Sun, Tianyi Lu, et al.. (2023). Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T‐cell lymphoma. Cancer Medicine. 12(23). 21138–21147. 2 indexed citations
12.
Zhang, Shuo, Cai Sun, Dashan Li, et al.. (2023). The prognostic value of controlling nutritional status (CONUT) score–based nomogram on extranodal natural killer/T cell lymphoma patients. Annals of Hematology. 102(6). 1433–1442. 5 indexed citations
13.
Li, Mingying, Dongmei Wang, Ying Zhou, et al.. (2023). NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc. Scientific Reports. 13(1). 8606–8606. 5 indexed citations
14.
Feng, Panpan, Dawei Chen, Xia Wang, et al.. (2022). Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia. Leukemia. 36(9). 2180–2188. 57 indexed citations
15.
Li, Mingying, Jingjing Ye, Meng Li, et al.. (2022). METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4. Leukemia. 36(11). 2586–2595. 59 indexed citations
16.
Ye, Jingjing, et al.. (2019). DNA‐Mediated Self‐Assembly and Metallization of Semiconductor Nanorods for the Fabrication of Nanoelectronic Interfaces. Chemistry - A European Journal. 25(38). 9012–9016. 16 indexed citations
19.
Pavlı́c̀ek, Adam, Maruja E. Lira, Nathan V. Lee, et al.. (2013). Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871). Molecular Cancer Therapeutics. 12(12). 2929–2939. 31 indexed citations
20.
Hook, Kenneth E., Maruja E. Lira, Keith A. Ching, et al.. (2012). An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735. Molecular Cancer Therapeutics. 11(3). 710–719. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026